HbA1C Reduced by Over 30% in Type 2 Diabetes Patients Taking Menon’s Nutraceutical Product
Menon Renewable Products, Inc. has recently concluded a randomized, oral safety and efficacy study of Menon’s latest nutraceutical product in patients with type-II diabetes and hyperlipidemia. Findings indicated that participants...